168 related articles for article (PubMed ID: 26310524)
1. Non Steroidal Anti Inflammatory Drugs As Gatekeepers Of Colon Carcinoma Highlight New Scenarios Beyond Cyclooxygenases Inhibition.
Guarnieri T
Curr Cancer Drug Targets; 2016; 16(2):186-97. PubMed ID: 26310524
[TBL] [Abstract][Full Text] [Related]
2. Changes in gene expression contribute to cancer prevention by COX inhibitors.
Baek SJ; Eling TE
Prog Lipid Res; 2006 Jan; 45(1):1-16. PubMed ID: 16337272
[TBL] [Abstract][Full Text] [Related]
3. Prevention of cancer in the upper gastrointestinal tract with COX-inhibition. Still an option?
Jiménez P; García A; Santander S; Piazuelo E
Curr Pharm Des; 2007; 13(22):2261-73. PubMed ID: 17691999
[TBL] [Abstract][Full Text] [Related]
4. COX inhibitors directly alter gene expression: role in cancer prevention?
Wang X; Baek SJ; Eling T
Cancer Metastasis Rev; 2011 Dec; 30(3-4):641-57. PubMed ID: 22020924
[TBL] [Abstract][Full Text] [Related]
5. Chemoprevention in gastrointestinal physiology and disease. Anti-inflammatory approaches for colorectal cancer chemoprevention.
Fajardo AM; Piazza GA
Am J Physiol Gastrointest Liver Physiol; 2015 Jul; 309(2):G59-70. PubMed ID: 26021807
[TBL] [Abstract][Full Text] [Related]
6. Prostaglandins and cancer.
Wang D; Dubois RN
Gut; 2006 Jan; 55(1):115-22. PubMed ID: 16118353
[TBL] [Abstract][Full Text] [Related]
7. Impact of non-steroidal anti-inflammatory drugs on gastrointestinal cancers: current state-of-the science.
Sahin IH; Hassan MM; Garrett CR
Cancer Lett; 2014 Apr; 345(2):249-57. PubMed ID: 24021750
[TBL] [Abstract][Full Text] [Related]
8. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.
Reddy BS; Hirose Y; Lubet R; Steele V; Kelloff G; Paulson S; Seibert K; Rao CV
Cancer Res; 2000 Jan; 60(2):293-7. PubMed ID: 10667579
[TBL] [Abstract][Full Text] [Related]
9. [Cyclooxygenase 2 inhibitors and cancer chemoprevention].
Masmoudi A; Chevalier TL; Sabatier L; Soria JC
Bull Cancer; 2004 May; 91 Suppl 2():S77-84. PubMed ID: 15899630
[TBL] [Abstract][Full Text] [Related]
10. NSAIDs and apoptosis.
Jana NR
Cell Mol Life Sci; 2008 May; 65(9):1295-301. PubMed ID: 18292966
[TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase inhibitors: From pharmacology to clinical read-outs.
Patrignani P; Patrono C
Biochim Biophys Acta; 2015 Apr; 1851(4):422-32. PubMed ID: 25263946
[TBL] [Abstract][Full Text] [Related]
12. Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors.
Grösch S; Maier TJ; Schiffmann S; Geisslinger G
J Natl Cancer Inst; 2006 Jun; 98(11):736-47. PubMed ID: 16757698
[TBL] [Abstract][Full Text] [Related]
13. Cancer prevention: a new era beyond cyclooxygenase-2.
Rigas B; Kashfi K
J Pharmacol Exp Ther; 2005 Jul; 314(1):1-8. PubMed ID: 15805430
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms and applications of non-steroidal anti-inflammatory drugs in the chemoprevention of cancer.
Steele VE; Hawk ET; Viner JL; Lubet RA
Mutat Res; 2003; 523-524():137-44. PubMed ID: 12628511
[TBL] [Abstract][Full Text] [Related]
15. Is inhibition of cyclooxygenase required for the chemopreventive effect of NSAIDs in colon cancer? A model reconciling the current contradiction.
Rigas B; Shiff SJ
Med Hypotheses; 2000 Feb; 54(2):210-5. PubMed ID: 10790755
[TBL] [Abstract][Full Text] [Related]
16. COX selectivity and animal models for colon cancer.
Oshima M; Taketo MM
Curr Pharm Des; 2002; 8(12):1021-34. PubMed ID: 11945149
[TBL] [Abstract][Full Text] [Related]
17. Cancer chemoprevention via activation of proteostatic modules.
Sklirou A; Papanagnou ED; Fokialakis N; Trougakos IP
Cancer Lett; 2018 Jan; 413():110-121. PubMed ID: 29107114
[TBL] [Abstract][Full Text] [Related]
18. Is inhibition of cyclooxygenase required for the anti-tumorigenic effects of nonsteroidal, anti-inflammatory drugs (NSAIDs)? In vitro versus in vivo results and the relevance for the prevention and treatment of cancer.
Raz A
Biochem Pharmacol; 2002 Feb; 63(3):343-7. PubMed ID: 11853685
[TBL] [Abstract][Full Text] [Related]
19. Anti-metastatic action of non-steroidal anti-inflammatory drugs.
Hung WC
Kaohsiung J Med Sci; 2008 Aug; 24(8):392-7. PubMed ID: 18926952
[TBL] [Abstract][Full Text] [Related]
20. Emerging roles for modulation of microRNA signatures in cancer chemoprevention.
Neelakandan K; Babu P; Nair S
Curr Cancer Drug Targets; 2012 Jul; 12(6):716-40. PubMed ID: 22515522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
